News

ELITechGroup

Filter

Open filter menu
Reset
Reset

ELITechGroup @ ECCMID 2018

ELITechGroup Molecular Diagnostics is very pleased to inform you about to this participation in the 28th ECCMID congress in Madrid and provides you more information about the event. ECCMID BOOTH (Booth # 32) The 2 topics are promoted this year by the Molecular Diagnostics : ELITe InGenius menu: the largest…

CE-IVD marking of the Respiratory Bacterial ELITe MGB® Panel for the detection of M.pneumoniae, C.pneumoniae and L.pneumophila

Puteaux, France, 12th February 2017 – ELITechGroup Molecular Diagnostics announces today the launch of a high-performance multiplex assay, Respiratory Bacterial ELITe MGB® Panel, for the diagnosis of bacterial respiratory infections, validated with ELITe InGenius®, ELITechGroup’s fully automated sample to result system. Respiratory infections are common causes of morbidity and mortality…

Hospital Artificial Intelligence

Artificial intelligence (AI) is being utilized in many different walks of life these days to improve people’s lives. From vehicles that are able to drive themselves to smartphones that react to the commands people give them and provide them with the information they need, AI has come a long way…

New Heart Failure Treatment Possibility

The number of people suffering from heart failure is expected to increase almost 50 percent over the course of the next 15 years. This is very troubling because, as of right now, about half of those who suffer from heart failure die within five years of being diagnosed. Their heart…

New Advancement in Cystic Fibrosis

Cystic fibrosis is a genetic disease that affects more than 70,000 people worldwide, with another 1,000 diagnosed with the disease each year. There are more than 1,700 known mutations of cystic fibrosis, complicating efforts to treat the disease. A new advancement in cystic fibrosis treatment involves growing mini-organs in a…

ELITechGroup Molecular Diagnostics announces the CE-IVD marking of the STI ELITe MGB® Panel, for the detection of C. trachomatis, N. gonorrhoeae and M. genitalium

Puteaux, France, 9th June 2017 – ELITechGroup Molecular Diagnostics announces the CE-IVD marking of the STI ELITe MGB® Panel: a multiplex assay for the detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Mycoplasma genitalium (MG), three major bacteria involved in Sexually Transmitted Infections. STIs are a global burden with more than 1…

ELITechGroup Molecular Diagnostics announces the CE-IVD marking of the Meningitis Viral 2 ELITe MGB® Panel for the detection of Enterovirus, Parechovirus, and Adenovirus with ELITe InGenius®

Puteaux, France, 6th July 2017 – ELITechGroup Molecular Diagnostics, announces today the launch of a high-performance real-time PCR assay: Meningitis Viral 2 ELITe MGB® Panel for viral meningitis diagnosis, validated with ELITe InGenius, ELITechGroup’s fully automated sample to result system.   To read more >>EMD PR Meningitis 201707“

ELITechGroup Molecular Diagnostics announces the CE-IVD marking of the STI ELITe MGB® Panel, for the detection of C. trachomatis, N. gonorrhoeae and M. genitalium

Puteaux, France, 9th June 2017 – ELITechGroup Molecular Diagnostics announces the CE-IVD marking of the STI ELITe MGB® Panel: a multiplex assay for the detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Mycoplasma genitalium (MG), three major bacteria involved in Sexually Transmitted Infections. STIs are a global burden with…

Molecular Diagnostics CVS Workshop

CVS 2017 Workshop ELITechGroup Molecular Diagnostics will be hosting an exclusive workshop at this year’s ASM Clinical Virology Symposium in Savannah, GA. The workshop will include lectures from distinguished speakers describing their experience using ELITe InGenius®, the highly flexible sample-to-result system designed for Molecular laboratories. Time & Location: Monday, May…

ELITechGroup SYMPOSIUM

Monday 24th April 2017 (Vienna – Austria) ELITechGroup Symposium (Molecular Diagnostics) : ELITe InGenius® the highly flexible sample-to-result solution (program) ELITechGroup Symposim (Microbiology) : Introducing the Rapid Polymyxin NP™ and Superpolymyxin™ tests, 2 new solutions for detecting and isolating Colistin-resistant strains (program) Contact your local representative for further information.”

Highlighting Vapor Pressure Osmometers

Vapor pressure osmometers are an essential mainstay in laboratories worldwide in research osmometry. ELITechGroup Biomedical Systems is the undisputed leader of vapor pressure osmometers, bringing both superior quality, methodology and accuracy to the process. Processing viscous, fluid or solid tissue specimens, ELITechGroup’s unique osmometers enables users to easily and quickly…

Highlighting Sweat Testing Products

Sweat-Chek™ Analyzer The sooner you get diagnosed with cystic fibrosis, the sooner you can start treatment to improve your quality of life and your lifespan. Known globally as the leader in a laboratory diagnosis of cystic fibrosis, ELITechGroup Biomedical Systems proudly offers several products to help with early diagnosing of…

ELITechGroup Molecular Diagnostics announced the CE-IVD marking of the Coagulation ELITe MGB® Kit, a multiplex assay for the detection of Factor V, Factor II, and MTHFR genetic variants

Puteaux, France, 27th January 2017 – ELITechGroup Molecular Diagnostics announced today the CE-IVD marking of the Coagulation ELITe MGB® Kit, a high-performance, multiplex assay for the detection of genetic variants associated with higher risk of deep venous thrombosis. Deep venous thrombosis is a multifactorial disease and major health problem which…

ELITechGroup Molecular Diagnostics announce the CE-IVD marking of the CRE ELITe MGB® Kit, for the detection of the Carbapenem Resistance genes of Enterobacteriaceae

Puteaux, France November 8th, 2016 – ELITechGroup Molecular Diagnostics announce today the CE-IVD marking of the CRE ELITe MGB® kit, a high-performance, qualitative, multiplex assay for the rapid detection of the Carbapenem Resistance genes of Enterobacteriaceae. In combination with the ELITe InGenius™, the ELITech Group’s fully automated sample-to-result system, the…

Molecular Diagnostics Advances Research and Treatment

The molecular diagnostics market is one of the fastest-growing segments in the medical diagnostics industry today. According to a study done by DPI Research, the market is projected to reach more than $30 billion by the year 2021. That makes it the largest segment of the in vitro diagnostic (IVD)…

Cystic Fibrosis Can Lead to Other Conditions

Macroduct Advanced and Baby
If you suffer from Cystic Fibrosis, then you already know the struggles associated with having the disease, but can CF lead to more? Recent studies have shown that it might. In a study published in the Cystic Fibrosis Journal, researchers were eager to determine the effects of Cystic Fibrosis and…

Hematology Industry Expected to Grow to $2.6B by 2020

The global hematology analyzers market is expected to grow to more than $2.6 billion by 2020, according to a recent study by technology advisory and research firm Technavio. The Technavio market report includes a detailed exploration of market trends and revenue for the industry and explores forecasts for different regions…

PSS and ELITechGroup reach OEM Agreement

Jan 7, 2015 Matsudo, Japan and Paris, France, January 5, 2015 – Precision System Science, Co., Ltd. (PSS) and The ELITech Group (ELITech) jointly announce that the companies have extended their relationship into a Development and Supply Agreement.Under and an exclusive OEM arrangement, PSS will develop and supply “geneLEADXII” instrument,…